Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese

Human Genetics

Volumn 100, Issue 3-4, 1997, Pages 327-333

  Ko, Yu Lin ^a   Ko, Yu Shien ^a   Wu, Shy Meeng ^a   Teng, Ming Sheng ^a   Chen, Fu Ru ^a   Hsu, Tsu Shiu ^a   Chiang, Chen Wen ^a   Lee, Ying Shiung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; LIPOPROTEIN LIPASE;

ADULT; ALLELE; ARTICLE; CHINESE; CHROMOSOME; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HOMOZYGOSITY; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

ALLELES; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; ASIAN CONTINENTAL ANCESTRY GROUP; DEOXYRIBONUCLEASE HINDIII; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0030930253     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050511     Document Type: Article

References (54)

1. Aalto-Setela K, Kontala K, Sane T, Nieminen M, Nikkila E (1987) DNA polymorphisms of apolipoprotein AI/CIII and insulin genes in familial hypertriglyceridaemia and coronary artery disease. Atherosclerosis 66:145-152
2. Ahn YI, Kamboh MI, Hamman RF, Cole SA, Ferrell RE (1993) Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 34:421-428
3. Albrink MJ, Meigs JW (1964) Interrelationship between skinfold thickness, serum lipids and blood sugar in normal men. Am J Clin Nutr 15:255-261
4. Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11:2-14
5. Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Enzi GB, Veriato F, Baiocchi MR, Sprecher DL, Kashyap ML, Brewer HB, Crepaldi G (1986) Apolipoprotein C-II deficiency syndrome: clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest 77:520-527
6. Bai H, Saku K, Liu R, Imamura M, Arakawa K (1995) Association between coronary artery disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 95: 102-104
7. Breckenridge WC, Little A, Steiner G, Chow A. Poapst M (1978) Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 298:1265-1273
8. Carlson LA, Holmquist L, Nilsson-Ehle P (1987) Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-α-triglyceridaemia. Acta Med Scand 219:435-447
9. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J (1989) DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 79:85-91
10. Connor SL, Connor MS, Connor WE, Sexton G, Calvin L, Bacon S (1982) The effects of age, body weight and family relationships on plasma lipoproteins and lipid in men, women and children of randomly selected families. Circulation 65:1290-1298
11. Cowan LD, Wilcosky T, Criqui MH, Barrett-Connor E, Suchindran CM, Wallace R, Laskarzewski P, Walden C (1985) Demographic, behavioral, biochemical, and dietary correlates of plasma triglycerides: lipid research clinics program prevalence study. Arteriosclerosis 5:466-480
12. Cox DW, Breckenridge WC, Little JA (1978) Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med 299:1421-1427
13. Cullen P, Farren B, Scott J, Farrall M (1994) Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hypertriglyceridemia. Arterioscler Thromb 14:1233-1249
14. Dammerman M, Sandkuul LA, Halaas JL, Chung W, Breslow JL (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 90:4562-4566
15. Ferns GAA, Stocks J, Ritchie C, Galton DJ (1985) Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet 11:300-303
16. Fisher RM, Maily F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ (1995) Interaction of the lipoprotein lipase asparagine 291→ serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 36:2104-2112
17. Gerdes C, Gerdes LV, Hansen PS, Faergeman O (1995) Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 92:1765-1769
18. Hayden MR, Kirk H, Clark C, Frohlich J, Rabkin S, McLeod R, Hewitt J (1987) DNA polymorphisms in and around the apo AI-CIII genes and genetic hyperlipidaemias. Am J Hum Genet 40:421-430
19. Heinzmann C, Kirchgessner T, Kwiterovich PO, Ladias JA, Derby C, Antonarakis SE, Lusis AJ (1991) DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible associations with high-density lipoprotein levels. Hum Genet 86:578-584
20. Heller DA, Faire U de, Pedersen NL, Dahlen G, McClearn GE (1993) Genetic and enviromental influences on serum lipid levels in twins. N Engl J Med 32:1150-1156
21. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Williams RR (1989) Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol 129:625-638
22. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249:790-793
23. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou JP, Bard JM, Fruchart JC, Apfelbaum M, Cambien F, Tiret L (1995) Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 36:2141-2146
24. Kessling AM, Horsthemke B, Humphries SE (1985) A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet 28:296-306
25. Laskarzewski P, Morrison JA, Mellies MJ, Kelly K, Gartside PS, Khoury P, Glueck CJ (1980) Relationships of measurements of body mass to plasma lipoprotein in school-children and adults. Am J Epidemiol 11:395-406
26. Law SW, Gray G, Brewer HB Jr, Sakaguchi AY, Naylor SL (1984) Human apolipoprotein A-I and C-III genes reside in the p11-q13 region of chromosome 11. Biochem Biophys Res Commun 118:934-942
27. Maily F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder F, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud PJ (1995) A common variant in the gene for lipoprotein lipase (Asp9→Asn): functional implications and prevalences in normal and hyperlipidemic subjects. Arterioscler Thromb Vase Biol 15:468-478
28. Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1:16-19
29. Mitchell RJ, Earl L, Bray P, Fripp YJ, Williams J (1994) DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides. Hum Biol 66:383-397
30. Nikkia EA (1983) Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease, 5th edn. McGraw Hill, New York pp 622-642
31. Ordovas J, Schaefer EJ, Salem D, Ward RH, Glueck CJ, Vergani C, Wilson PWF, Karathanasis SK (1986) Apolipoprotein A-1 gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med 314:671-677
32. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE (1992) Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteines and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 97:171-185
33. Phillips NR, Havel RJ, Kane JP (1981) Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides: association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis 1:13-24
34. Pi-Sunyer FX (1991) Health implications of obesity. Am J Clin Nutr 53:1595S-1603S.
35. Pi-Sunyer FX (1993) Medical hazards of obesity. Ann Intern Med 119:655-660
36. Price WH, Morris SW, Kitchin AH, Wenham PR, Burgon PRS, Donald PM (1989) DNA restriction fragment length polymorphisms as markers of familial coronary artery disease. Lancet 1:1407-1410
37. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC Katz J, Jowett NI, Baralle FE, Galton DJ (1985a) Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. J Clin Invest 76:1090-1095
38. Rees A, Stocks J, Williams LG, Caplin JL, Jowett NI, Camm AJ, Galton JL (1985b) DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis 58:269-275
39. Rees A, Stocks J, Paul H, Ohuchi Y, Galton D (1986) Haplotypes identified by DNA polymorphism at the apolipoprotein A-l and C-III loci and hypertriglyceridaemia: a study in a Japanese population. Hum Genet 72:168-171
40. Reymer PWA, Gagne E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein J, Hayden MR (1995) A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 10:28-33
41. Shoulders CC, Ball MJ, Mann JI, Baralle FE (1986) Genetic marker in apolipoprotein AI/CIII gene complex associated with hypercholesterolaemia. Lancet 11:1286-1287
42. Shoulders CC, Grantham TT, North JD, Gaspardone A, Fabrizo T, Fazio A de, Versaci F, Cox NJ (1996) Hypertriglyceridermia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children. Hum Genet 98:557-566
43. Sparkes RS, Zollman S, Klisak I, Kirchgessner TG, Komaromy MC, Mohandas T, Schotz MC, Lusis AJ (1987) Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8q22 and hepatic lipase to 15q21. Genomics 1:138-144
44. Stocks J, Paul H, Galton DJ (1987) Haplotypes identified by DNA RFLP in the apo AI/CIII/AIV gene region and hypertriglyceridaemia. Am J Hum Genet 41:106-118
45. Stunkard AJ (1996) Current views on obesity. Am J Med 100: 230-236
46. Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E (1996) Polymorphic markers in apolipoprotein CIII gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vase Biol 16:941-947
47. Thorn JA, Chamberlain JC, Alcolado JC, Oka K, Chan L, Stocks J, Galton DJ (1990) Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 85:55-60
48. Vogler GP, Sorensen TIA, Stunkard AJ, Srinivasan MR, Rao DC (1995) Influences of genes and shared family environment on adult body mass index assessed by a comprehensive path model in an adoption study. Int J Obesity 19:40-45
49. Wang CS, Mconathy WJ, Kloer H, Alaupovic P (1985) Modulation of lipoprotein lipase activity by apolipoproteins: effects of apolipoprotein C-III. J Clin Invest 75:384-390
50. Wang XL, McCredie RM, Wilcken DEL (1996) Common DNA polymorphisms at the lipoprotein lipase gene: association with severity of coronary artery disease and diabetes. Circulation 93:1339-1345
51. William LW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T (1995) Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest 96:2601-2605
52. Windler E, Chao Y, Harvel RJ (1980) Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J Biol Chem 255:5475-5480
53. Witztum JL, Dillingham MA, GreseW, Bateman J, DiekmanC, Blaufuss C, Weidman S, Schonfeld G (1980) Normalization of triglycerides in type IV hyperlipoproteinemia fails to correct low levels of high-density-lipoprotein cholesterol. N Engl J Med 303:907-914
54. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J (1995) An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 95:371-375